BioDelivery Sciences International (NASDAQ:BDSI) Announces Full Enrollment in...
By VFC’s Stock House In October BioDelivery Sciences International (NASDAQ:BDSI) announced positive Phase II results for BEMA Buprenorphine in the treatment of chronic pain, and it was announced on...
View ArticleTitan Pharmaceuticals (OTC:TTNP): Earnings Date
By VFC’s Stock House Shares of Titan Pharmaceuticals (OTC:TTNP) jumped late last month after a positive meeting with the FDA indicated that the approval path for Probuphine, a treatment for opioid...
View ArticleUpdate: Legal Developments Bode Well For BioDelivery Sciences International...
By VFC’s Stock House This morning, VFC’s Stock House highlighted some important developments for BioDelivery Sciences International, Inc. (NASDAQ:BDSI), both on the legal and pipeline fronts. Since...
View ArticleVolume Watch: Titan Pharmaceuticals (TTNP) Shares Picking Up The Trading Pace
By VFC’s Stock House Investors impatient with the lack of information flowing from Titan Pharmaceuticals, Inc. (OTC:TTNP) likely bailed out as the stock slipped below the dollar mark on large volume a...
View ArticleWeekly Stock Watch: AMRN, SGYP, IRWD, FRX, SSH, NBS, ACTC, AEZS, KERX, TTNP
By VFC’s Stock House The markets flew last Thursday afternoon and Friday morning after much-anticipated comments from the US Federal Reserve indicated that stimulus for the ailing economy would...
View ArticleTitan Pharmaceuticals (OTC:TTNP): Back In The Ballgame
By VFC’s Stock House Shares of Titan Pharmaceuticals, Inc. (OTC:TTNP) have traded in a relative range between sixty five and eighty cents since mid-April of this year, but a nice bump in volume over...
View ArticleChronic Pain Sufferers May Rest “Assured” With This Small Pharmacy (APHY,...
By Phil Lassiter Pain Medications: Not a Painless Task to Acquire When one thinks of pharmacy companies, any of the large corporate brands can come to mind, depending on where you live. The pharmacy...
View ArticleIndustry Trends May Be Shifting Towards Boutique Pharmacy Services: APHY,...
By VFC’s Stock House Discovering industry trends early and then establishing positions in companies who may benefit from those trends ahead of the general market could quickly turn into a successful...
View ArticleAssured Pharmacy (APHY): A Possible New Drug Abuse Deterrence Business Model
By ChemistFrog The healthcare sector provides a diverse group of investment candidates for investors of many types. From the dividend-paying $66.72 billion heavyweight Bristol Myers Squibb Co....
View ArticleDon’t Let These Five Speculative Stock Plays Slip Below The Radar: FPMI,...
By VFC’s Stock House On numerous occasions during the record-breaking rally of 2013 we’ve pointed out the fact that the more speculative and ‘under the radar’ sectors of the investing world are often...
View ArticleSpecialty Pharmacies Offer Solutions — Also For Investors: PMC, BIOS, APHY
By Dutch Trader In 2012, Americans filled more than 4 billion prescriptions at 62,000 retail, mail, and specialty pharmacies. The largest U.S. pharmacies ranked by total prescription you will find in...
View ArticleAffordable Care Act Will Benefit Drugstores Treating Chronic Illnesses: APHY,...
By Yagmur Kurt Pharmacy stocks have been some of the best performers over the past two years, despite lower overall sales, due to an increase in newly available generics. For example, Costco Wholesale...
View Article
